Home  >  News
Msc_Jun22 Advertisement
you can get e-magazine links on WhatsApp. Click here
  Ipsen to acquire biopharmaceutical company, Epizyme,   June 28, 2022
  New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta had no evidence of disease activity,   June 28, 2022
  EU CHMP recommends approval of Lynparza as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer,   June 28, 2022
  Teva presents positive interim results from PEARL study of Ajoy in patients with chronic migraine or episodic migraine at EAN congress,   June 27, 2022
  Researchers find oral antiviral drug that could provide an effective treatment against respiratory syncytial virus,   June 27, 2022
  WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics,   June 27, 2022
  Harrow Health introduces Iopidine 1% and Maxitrol in US markets,   June 27, 2022
  US FDA accepts Emergent BioSolutions’ BLA for AV7909 anthrax vaccine candidate,   June 27, 2022
  Intellia, Regeneron announce positive interim data from phase 1 study of CRISPR-based NTLA-2001 to treat transthyretin amyloidosis,   June 27, 2022
  EMA committee recommends approval of Janssen’s Imbruvica in fixed-duration combination with venetoclax for adult patients with previously untreated CLL,   June 27, 2022
  CHMP recommends conditional marketing authorization to BioMarin’s valoctocogene roxaparvovec gene therapy to treat adults with severe hemophilia A,   June 27, 2022
  UTHealth Houston study shows flu vaccination linked to 40% reduced risk of Alzheimer’s disease,   June 27, 2022
  Bristol Myers Squibb’s CAR T cell therapy, Breyanzi gets US FDA approval for relapsed or refractory LBCL after one prior therapy,   June 27, 2022
  EMA committee recommends marketing approval for Novartis’ Scemblix to treat adult patients with chronic myeloid leukaemia,   June 27, 2022
  Therma Bright seeks Health Canada approval for AcuVid Covid-19 Rapid Antigen Saliva Test for PoC,   June 25, 2022
  EMA committee recommends approval of argenx’s efgartigimod to generalized myasthenia gravis,   June 25, 2022
  EMA committee recommends expanded conditional marketing approval for Novavax Covid-19 vaccine, Nuvaxovid for adolescents aged 12 through 17,   June 25, 2022
  IONIQ Sciences introduces next-generation early-stage cancer detection platform, LUNA3,   June 25, 2022
  FoCus phase III trial of ALXN1840 shows rapid and sustained improvement in copper mobilisation from tissues, potentially closing treatment gaps for Wilson disease community,   June 25, 2022
  China NMPA approves intravenous formulation of Cresemba to treat invasive aspergillosis and invasive mucormycosis,   June 25, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |